Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company’s ...

$ 1.0701-0.0599-5.30% ...

At close: April 21 at 4:00:01 PM EDT ...

The April 21 death of Pope Francis triggered a period of mourning in the Catholic Church, but also kick-started the race for ...

Pope Francis, who died Monday aged 88, will go down in history as a radical pontiff, a champion of underdogs who forged a ...

The funeral for Pope Francis will follow many traditions, but also skip some customs after the pope amended the Catholic ...

After Russia invaded Ukraine in February 2022, Pope Francis regularly referred to Ukraine and its people as “martyred” and ...

Global Wealth Management reported net revenues of $850.6 million for the three months ended March 31, 2025 compared with $790 ...

Edwards Lifesciences reports 8% Q1 2025 sales growth to $1.41B, driven by TAVR & TMTT. Discover regulatory catalysts & future growth insights.